Free Trial
NYSEARCA:HRTS

Tema Obesity & Cardiometabolic ETF (HRTS) Price, Holdings, & News

$35.53
+0.86 (+2.48%)
(As of 11:33 AM ET)

About Tema Obesity & Cardiometabolic ETF (NYSEARCA:HRTS)

Key Stats

Today's Range
$35.09
$35.53
50-Day Range
$32.05
$35.90
52-Week Range
$26.26
$36.03
Volume
4,982 shs
Average Volume
25,679 shs
Market Capitalization
$67.15 million
Assets Under Management
$524,000.00
Dividend Yield
N/A
Net Expense Ratio
0.00%
Aggregate Rating
Moderate Buy

ETF Overview

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.

Tema Obesity & Cardiometabolic ETF Expenses

TypeHRTSNYSEARCA ETFsAll ETFs
Management Fee0.00%0.51%0.52%
Other Expenses0.00%0.58%0.54%
Total Expense0.00%0.73%0.71%
Fee Waiver0.00%-0.68%-0.58%
Net Expense0.00%0.58%0.59%
Receive HRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tema Obesity & Cardiometabolic ETF and its competitors with MarketBeat's FREE daily newsletter.

HRTS ETF News Headlines

HRTS: Generating Alpha In Obesity Treatment
Trump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absolute
Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.
See More Headlines

HRTS ETF - Frequently Asked Questions

Tema Obesity & Cardiometabolic ETF's stock was trading at $30.61 at the start of the year. Since then, HRTS stock has increased by 16.1% and is now trading at $35.53.
View the best growth stocks for 2024 here
.

Shares of HRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Fund Details

Issuer
Fund Name
Tema Cardiovascular and Metabolics ETF
Tax Classification
Current Symbol
NYSEARCA:HRTS
Inception Date
1/1/2100
Fund Manager
N/A
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Benchmark
N/A
Category
Focus
Development Level
Region
Number of Holdings
40

Fund Statistics

Assets Under Management
$524,000.00
Average Daily Volume
$0.00
Discount/Premium
0.43%

Administrator, Advisor and Custodian

Administrator
N/A
Advisor
N/A
Custodian
N/A
Distributor
N/A
Transfer Agent
N/A
Trustee
N/A
Lead Market Maker
N/A

Miscellaneous

Beta
0.93
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Top 10 HRTS Holdings

HRTS Sector Exposure

HRTS Industry Exposure


This page (NYSEARCA:HRTS) was last updated on 9/19/2024 by MarketBeat.com Staff
From Our Partners